+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
VANTABIO VANTABIO

Vanta Bioscience Share Price

₹19.64 -1.03 (-4.98%)
32.28% Fall from 52W High

13 Aug, 2026 4:01 PM (IST)

Vanta Bioscience live price: ₹19.64. It opened at ₹20 vs previous close ₹21; intraday high/low: ₹20/₹20. The 50 & 200 DMA stand at ₹21.60/₹26.40.

Vanta Bioscience Performance

  • Today's Low
  • ₹20
  • Today's High
  • ₹20
  • 52 Week Low
  • ₹15
  • 52 Week High
  • ₹29
  • Open Price₹20
  • Previous Close₹21
  • Volume1,500
  • 50 DMA₹21.60
  • 100 DMA₹22.00
  • 200 DMA₹26.40

Vanta Bioscience Chart

Investment Returns

  • Over 1 Month -22.34%
  • Over 3 Month + 9.11%
  • Over 6 Month -1.26%
  • Over 1 Year -23.4%

Smart Investing Starts Here Start SIP with Vanta Bioscience for Steady Growth!

Invest Now

Vanta Bioscience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 129
  • PEG Ratio
  • -
  • Market Cap Cr
  • 14
  • P/B Ratio
  • 0.7
  • Average True Range
  • 1
  • EPS
  • 0.2
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.2
  • RSI
  • 38.06
  • MFI
  • 24.59

Latest Stock News Updates

Vanta Bioscience Ltd - 540729 - Audited Standalone And Consolidated Financial Results For The Half Year And Financial Year Ended March 31, 2026

Audited standalone and consolidated Financial Results for the half year and financial year ended March 31, 2026

Vanta Bioscience Ltd - 540729 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 30.05.2026

Outcome of the Board Meeting held on 30.05.2026

Vanta Bioscience Ltd - 540729 - Board Meeting Intimation for Approval Of Standalone And Consolidated Audited Financial Results For The Half Year And Financial Year Ended March 31, 2026 - Board Meeting To Be Held On May 30, 2026

Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the half year and the financial year ended March 31, 2026 and to take note of the Audit Reports issued by the Statutory Auditors thereon

Vanta Bioscience Financials

Vanta Bioscience Technicals

EMA & SMA

Current Price
₹19.64
-1.03 (-4.98%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹22.60
  • 50 Day
  • ₹21.60
  • 100 Day
  • ₹22.00
  • 200 Day
  • ₹26.40

Resistance and Support

19.61 Pivot Speed
  • R3 19.60
  • R2 19.60
  • R1 19.60
  • S1 19.60
  • S2 19.60
  • S3 19.60

Vanta Bioscience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-30 Audited Results
2025-11-14 Half Yearly Results
2025-08-01 Audited Results (Revised)
2024-12-06 Increase in Authorised Capital Inter alia, to consider : (1) Conversion of unsecured loans from Promoters and others into equity shares and increase in the authorized capital as per requirement
2024-11-14 Half Yearly Results

Vanta Bioscience Shareholding Pattern

72.81%
27.18%
0%

Vanta Bioscience FAQs

Vanta Bioscience share price is ₹19 As on 16 August, 2026 | 00:29

The Market Cap of Vanta Bioscience is ₹14 Cr As on 16 August, 2026 | 00:29

The P/E ratio of Vanta Bioscience is 129 As on 16 August, 2026 | 00:29

The PB ratio of Vanta Bioscience is 0.7 As on 16 August, 2026 | 00:29

The 52 week High & Low of Vanta Bioscience is ₹29/₹14.7 respectively As on 16 August, 2026 | 00:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23